Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South — Austin, Texas

Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South is a clinical research site located in Austin, Texas, United States 78731.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC).

Sponsors: Nuvation Bio Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South?

Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South conducted?

Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer (NSCLC).

Is Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South accredited by Crixeo Health?

Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.